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Functional genomics: The worm scores a knockout
Stuart K. Kim
Following the completion of the genome sequence of
Caenorhabditis elegans, four independent studies have
now assessed the functions of more than a third of the
worm’s genes by analysing the phenotypes caused
when each of a large set of genes is inactivated by RNA
interference. 
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The success of the various genome projects has provided
enormous resources for studying biological processes on a
grand scale. Among metazoa, the complete sequence of
the nematode Caenorhabditis elegans was reported in 1998
[1], followed by that of the fruitfly Drosophila [2] in 2000;
the human genome sequence has been completed and
will be published early this year. With the DNA sequence
completed, we are confronted with the enormous chal-
lenge of uncovering the functions of the genes defined by
the genome projects. The magnitude of this challenge is
enormous: in C. elegans, so far only 1572 genes have been
studied at the biochemical or genetic levels, out of a total
of 18,972 genes — just 8% of the genome [3]. It is clear
that we need to use functional genomics approaches to
address gene functions on a global scale.
Now four papers, two in Current Biology [4,5] — one [5]
elsewhere in this issue — and two in Nature [6,7], have
reported important advances in C. elegans functional
genomics. These studies represent the largest attempt so
far to document the mutant phenotypes of many genes in
parallel in a given species. All four groups used the tech-
nique of double-stranded (ds)RNA-mediated interference
(RNAi) to determine the loss-of-function phenotype of
genes comprising in total about one-third of the genome.
Genetic screens using RNAi have an advantage over con-
ventional mutagenesis approaches, as the genetic map
position and molecular nature of the gene are already
known. These data will be an incredibly useful resource
for those working directly on C. elegans. And as basic gene
functions are often conserved, the data will also be infor-
mative for those working on related genes in other species.
The technique that all four groups used, RNAi, is based
on a fascinating biological phenomenon [8]. In many
species, expression of a particular dsRNA sequence has
been shown to cause the specific degradation of the
corresponding mRNA, resulting in a nearly complete loss-
of-function phenotype. Thus, one can use RNAi to effi-
ciently find mutant phenotypes for genes defined by
sequence, without having to identify mutations in the
gene itself, greatly speeding up analysis of mutant pheno-
types. RNAi works exceptionally well in C. elegans, and the
dsRNA can be delivered by injection, by soaking worms
in a solution of dsRNA, or by feeding worms bacteria
expressing dsRNA. Delivering dsRNA by feeding is par-
ticularly useful, because it is less labor intensive than
microinjection and could thus be used by many labs to
subsequently repeat the whole-genome RNAi screen to
search for particular RNAi phenotypes.
The four studies [4–7] illustrate the power of RNAi on
a whole genome level. Hyman’s group [6] systematically
analyzed the RNAi phenotype of nearly all of the genes
on C. elegans chromosome III — 2,174 genes, 96% of
the genes on chromosome III. They designed polymerase
chain reaction (PCR) primers to amplify genomic regions
corresponding to each gene on chromosome III, prepared
dsRNA from the PCR products and injected the dsRNAs
into worms. They then observed visible phenotypes
using a dissecting microscope, and cellular phenotypes
using time-lapse differential interference contrast (DIC)
microscopy. As in all four studies, there was good agree-
ment between results obtained using RNAi and previ-
ously reported germ-line and embryonic phenotypes
(20/24 genes), but only moderate agreement for previously
reported larval or adult phenotypes (9/31 genes). The
experiment revealed 281 genes (12.9%) with an RNAi
phenotype, including 133 with a cellular phenotype.
These 133 genes include those involved in meiosis, nuclear
appearance, cell division, the pace of development and
embryonic morphology. 
In order to enrich for genes that function in the germ line
or in embryogenesis, the Kemphues group [4] prepared
an oocyte cDNA library. They used RNAi on 350 different
oocyte cDNAs, and found a set of 81 non-redundant cDNA
clones with essential roles in embryogenesis. In a similar
manner to Hyman’s group, Kemphues and colleagues
used time-lapse recordings of early embryogenesis, which
revealed cellular defects in relatively high detail. The high
resolution provided by time-lapse recording of individual
embryonic cells is important, because the level of detail in
many cases suggests which specific cell or developmental
events are defective in the RNAi-treated embryos.
Sugimoto’s group [5], whose paper appears elsewhere in
this issue, examined the RNAi phenotype of 2,479 genes
defined by non-redundant cDNA clones. They prepared
dsRNA from each of the cDNA clones, soaked worms
in the dsRNA, and then scored the rough phenotype —
such as embryonic or larval lethal — using a dissecting
microscope. They found 675 genes (27%) showing a gross
phenotype at the level of the dissecting microscope. 
Finally, Ahringer’s group [7] focused on genes from
chromosome I. A key advantage of the approach used by
this group is that they induced RNAi by feeding bacteria
expressing dsRNA to worms. They prepared PCR frag-
ments corresponding to genes on chromosome I, cloned
each into an expression vector for dsRNA, and produced a
library of bacterial strains corresponding to 2,416 genes
from chromosome I (87%). They fed these dsRNA-
producing bacteria to worms, scored a wide range of phe-
notypes using a dissecting scope, and found a total of
339 genes (13.9%) with clear phenotypes. An important
aspect of this experimental approach is that, once made,
the library of dsRNA-producing bacteria can be used again
by other researchers in subsequent screens for particular
RNAi phenotypes.
The four groups collectively analyzed RNAi phenotypes
from more than 6275 genes — 33% of the genome — and
found phenotypes for more than 888 genes (Table 1).
This is a significant accomplishment. The work described
here adds to the mutant phenotypes being assembled by
the C. elegans knockout consortium. In most cases, the
phenotypes of these genes were not previously known;
for example, in the work by Ahringer and colleagues [7],
the 339 genes with phenotypes included 308 in genes
for which no phenotype had previously been described.
Previously, there was a total of 1572 C. elegans genes in
which both the DNA sequence and mutant phenotypes
were known [3]. Many of these genes have subtle
mutant phenotypes, such as defective osmotic avoidance
or chemosensation, such that only about 1173 genes have
a mutant phenotype that would have been detected in
these four RNAi studies ([3]; P. Gonczy, personal commu-
nication). Hence, the RNAi screens identified about 56%
as many genes as had been previously known, or approxi-
mately 76% as many genes including only those with phe-
notypes that would have been scored in the RNAi projects.
These four global RNAi studies have provided functional
information about a significant portion of the genome,
albeit at a shallow level. Although the time-lapse video
recordings performed by the Hyman [6] and Kemphues
[4] groups documented the cellular RNAi phenotypes in
reasonable detail, the mutant phenotypes for each of the
genes could be studied in far greater detail, including
analysis using molecular markers and the isolation of
genetic mutations. There is great excitement and anticipa-
tion that the remaining two thirds of the genes in the C.
elegans genome will soon be scanned using RNAi, achiev-
ing a milestone in the ‘C. elegans functional genome
project’. Now that they have worked out the experimental
approach for the first third of the genome, the C. elegans
groups seem well poised to finish most of the remainder of
the genome in relatively short order.
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Table 1
Summary of the results of the four recent C. elegans functional genomics studies.
Group RNAi method Genes No. genes analyzed No. genes with phenotypes
Hyman [6] Injection Chromosome III 2,174 281
Kemphues [4] Injection Oocyte cDNAs 350* 81
Sugimoto [5] Soaking ESTs 2,479 675
Ahringer [7] Feeding dsRNA Chromosome I 2,416 339
Total > 6,275 (33%)† > 888†
*Number of cDNA clones, some of which represent identical genes. †These totals do not include those from Piano et al. [4].
Figure 1
An illustration of the kinds of functional genomic approaches being
taken with C. elegans. Data from each of these approaches can be
found at these web sites: function, http://mpi-web.embl-
heidelberg.de/dbScreen/, www.wormbase.org,
http://watson.genes.nig.ac.jp/db/rnai_s/index.html, www.rnai.org and
http://elegans.bcgsc.bc.ca/knockout.shtml; annotation,
http://www.proteome.com/databases/ and http://www.wormbase.org/;
expression, http://cmgm.stanford.edu/~kimlab/wmdirectorybig.html
and ftp://spliceome.org/pub/Chip_Data; protein interaction,
http://cancerbiology.dfci.harvard.edu/cancerbiology/ResLabs/Vidal/
Functional genomic studies in C. elegans are advancing
rapidly along a number of different and interconnected
fronts. Along with the RNAi work discussed here, gene
functions are being determined by annotation of the
genome, by expression analysis using DNA microarrays
and by finding protein-binding interactions using a global
yeast two-hybrid approach (Figure 1) [3,9–13]. Together,
these approaches will deliver information on the basic
properties of gene function: sequence, mutant phenotype,
expression profile and protein-binding interaction. These
approaches make C. elegans an attractive model organism
for genetics and functional genomics, serving not only
those that already work on C. elegans but also those that
work on genes in other organisms with a function conserved
in C. elegans.
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